Empiric Antimicrobial Therapy for Febrile Granulocytopenic Cancer Patients: Lessons from four EORTC trials

Authors

  • J. Klastersky Service de Medecine Interne et Laboratoire d'Investigation Clinique H. J. Tagnon, Institut Jules Bordet, Centre Des Tumeurs De l'Universite Libre De Bruxelles, 1 Rue Heger-Bordet, B-1000, Bruxelles, Belgium

DOI:

https://doi.org/10.3109/02841868809093577

Keywords:

Granulocytopenic cancer patients, antimicrobial therapy, EORTC trials

Abstract

The experience from four EORTC trials on antimicrobial therapy for febrile granulocytopenic cancer patients (GCP) is reviewed. A general conclusion from these trials is that studies of the management of infection in GCP should include sufficient numbers of eligible patients to allow for evaluation of bacteremic patients at highest risk of death. The need for large collaborative studies stems directly from these considerations.

Downloads

Download data is not yet available.

Downloads

Published

1988-01-01

How to Cite

Klastersky, J. (1988). Empiric Antimicrobial Therapy for Febrile Granulocytopenic Cancer Patients: Lessons from four EORTC trials. Acta Oncologica, 27(5), 497–502. https://doi.org/10.3109/02841868809093577

Issue

Vol. 27 No. 5 (1988): Acta Oncologica

Section

Articles